Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 169 | 0 | 16 | 48 | 0 |
| Gross Profit | 169 | N/A | 16 | 48 | N/A |
| Operating Expenses | 19,776 | 15,526 | 17,693 | 13,472 | 11,447 |
| Operating Income | -19,607 | -15,526 | -17,677 | -13,424 | -11,447 |
| Other Income | 257 | 444 | 538 | 580 | 1,229 |
| Pre-tax Income | -19,350 | -15,082 | -17,139 | -12,844 | -10,218 |
| Income Tax | 48 | 27 | 61 | 55 | 54 |
| Net Income Continuous | -19,398 | -15,109 | -17,200 | -12,899 | -10,272 |
| Net Income | $-19,398 | $-15,109 | $-17,200 | $-12,899 | $-10,272 |
| EPS Basic Total Ops | -0.34 | -0.27 | -0.31 | -0.23 | -0.19 |
| EPS Basic Continuous Ops | -0.34 | -0.27 | -0.31 | -0.23 | -0.19 |
| EPS Diluted Total Ops | -0.34 | -0.27 | -0.31 | -0.23 | -0.19 |
| EPS Diluted Continuous Ops | -0.34 | -0.27 | -0.31 | -0.23 | -0.19 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.27 | -0.31 | -0.23 | -0.19 |
| EBITDA(a) | $-19,443 | $-15,345 | $-17,498 | $-13,253 | $-11,274 |